Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer

CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer

US Patent 10993945 · Granted May 4, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quinoline-based compounds and methods of inhibiting CDK8/192025
Bicyclic pyridine compositions and methods of using the same for cancer therapy2023
Quinoline-based compounds and methods of inhibiting CDK8/192021
Cell-based methods for measuring activity of a protein inhibitor2020
Cell-based methods for measuring activity of a protein inhibitor2020
Method for treating prostate cancer2017
CDKI pathway inhibitors and uses thereof2016
CDKI pathway inhibitors and uses thereof2016
CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreven2016
CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreven2016
CDKI pathway inhibitors and uses thereof2013
CDKI pathway inhibitors and uses thereof2013